SM
CYNA

Sabby Management’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Sabby Management’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,194
Closed -$305K – 366
2016
Q2 		$305K Sell
18,194
-48,328
-73% -$650K 0.02% 230
2016
Q1 		$792K Buy
66,522
+7,912
+13% +$106K 0.04% 175
2015
Q4 		$905K Buy
58,610
+6,441
+12% +$97.9K 0.05% 197
2015
Q3 		$845K Buy
52,169
+32,866
+170% +$534K 0.03% 255
2015
Q2 		$314K Buy
+19,303
New +$317K 0.01% 277

Other funds holding CYNA

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BHMP
Bardin Hill Management Partners New York $80.3M AUM 31.39% 1-Year Est. Return
CC
Coastland Capital Palo Alto, California $1.6B AUM 29.3% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Sabby Management's CYNA Position: Q3 2016 in Review

Sabby Management sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q3 2016, closing a stake of 18,194 shares — an estimated $305K sold.

Sabby Management first reported a position in CYNA in Q2 2015 and held it in 5 quarters. The position peaked at $905K in Q4 2015. 60 funds tracked by Wall St. Rank hold CYNA as of Q3 2016.

  • Sabby Management reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q3 2016 after selling out during the quarter.
  • Sabby Management sold 18,194 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q3 2016, an estimated $305K.
  • Sabby Management first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 5 quarters.
  • Sabby Management's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $905K in Q4 2015.
  • 60 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q3 2016.

Based on Sabby Management's 13F filing for Q3 2016, filed 14 Nov 2016.